Table 1 Characteristics of patients in the study cohort that were assessed using univariate and multivariate analysis as risk factors for the presence of residual blast cells in peripheral blood on day 8 following prednisone chemotherapy
Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
No blasts (n = 24) | Residual blasts (n = 33) | Crude OR (95% CI) | P value | Adjusted OR (95% CI) | P value | |
Age (months) | 53 (37–71) | 74 (50–148) | 1.01 (1.00–1.02) | 0.074 | 1.008 (0.996–1.019) | 0.18 |
Height (cm) | 99.2 (91.2–110) | 125 (103–149) | 1.04 (1.01–1.07) | 0.013 | ||
Weight (kg) | 16.3 (12.9–20.2) | 19.8 (16–35) | 1.05 (1.00–1.10) | 0.053 | ||
Gender (male) (%) | 9 (37.5) | 20 (60.6) | 0.45 (0.15–1.33) | 0.67 | ||
ASA-PS≧III (%) | 2 (8.3) | 2 (6.1) | 0.66 (0.086–5.02) | 0.53 | ||
Operation time (min) | 29 (23–47) | 27 (22–30) | 0.97 (0.93–1.01) | 0.15 | ||
Anesthesia time (min) | 83 (73–92) | 83 (74–92) | 0.99 (0.97–1.01) | 0.45 | ||
Anesthesia method (sevoflurane) (%) | 12 (50.0) | 7 (21.2) | 0.27 (0.085–0.86) | 0.045 | 2.31 (0.70–7.65) | 0.17 |
WBC > 50,000/μL at diagnosis (%) | 2 (8.3) | 8 (24.2) | 3.23 (0.619–16.9) | 0.18 | ||
Central nervous invasion (%) | 1 (4.2) | 5 (15.2) | 3.79 (0.413–34.8) | 0.39 | ||
Mediastinal invasion (%) | 0 (0) | 0 (0) | ||||
Hypodiploid (%) | 1 (4.2) | 0 (0) | 0.393 (0.284–0.554) | 0.40 | ||
Genetic risk (%) | 1 (4.2) | 6 (18.2) | 4.714 (0.528–42.10) | 0.22 | ||